Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2014 4
2015 5
2016 2
2017 8
2018 6
2019 5
2020 7
2021 10
2022 13
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
Mateo-Urdiales A, Sacco C, Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. Among authors: del manso m. JAMA Netw Open. 2023 Oct 2;6(10):e2336854. doi: 10.1001/jamanetworkopen.2023.36854. JAMA Netw Open. 2023. PMID: 37792377 Free PMC article.
Pediatric COVID-19 Cases Prelockdown and Postlockdown in Italy.
Bellino S, Rota MC, Riccardo F, Andrianou X, Mateo Urdiales A, Del Manso M, Punzo O, Bella A, Villani A, Pezzotti P; COVID-19 Working Group. Bellino S, et al. Among authors: del manso m. Pediatrics. 2021 Feb;147(2):e2020035238. doi: 10.1542/peds.2020-035238. Epub 2020 Nov 5. Pediatrics. 2021. PMID: 33154154 No abstract available.
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023.
Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Fotakis EA, Petrone D, Del Manso M, Siddu A, Stefanelli P, Bella A, Riccardo F, Rezza G, Palamara AT, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: del manso m. Euro Surveill. 2023 Aug;28(32):2300397. doi: 10.2807/1560-7917.ES.2023.28.32.2300397. Euro Surveill. 2023. PMID: 37561053 Free PMC article.
Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy.
Guzzetta G, Riccardo F, Marziano V, Poletti P, Trentini F, Bella A, Andrianou X, Del Manso M, Fabiani M, Bellino S, Boros S, Urdiales AM, Vescio MF, Piccioli A; COVID-19 Working Group,2; Brusaferro S, Rezza G, Pezzotti P, Ajelli M, Merler S. Guzzetta G, et al. Among authors: del manso m. Emerg Infect Dis. 2021 Jan;27(1):267-70. doi: 10.3201/eid2701.202114. Epub 2020 Oct 20. Emerg Infect Dis. 2021. PMID: 33080168 Free PMC article.
Characteristics of COVID-19 cases in Italy from a sex/gender perspective.
D'Archivio M, Cataldo C, Del Manso M, Petrone D, Sacco C, Vescio MF, Spuri M, Rota MC, Bressi M, Fabiani M, Boros S, Urdiales AM, Riccardo F, Bella A, Masella R, Pezzotti P, Busani L. D'Archivio M, et al. Among authors: del manso m. Ann Ist Super Sanita. 2022 Oct-Dec;58(4):227-235. doi: 10.4415/ANN_22_04_02. Ann Ist Super Sanita. 2022. PMID: 36511193 Free article.
COVID-19 response: effectiveness of weekly rapid risk assessments, Italy.
Riccardo F, Guzzetta G, Urdiales AM, Del Manso M, Andrianou XD, Bella A, Pezzotti P, Carbone S, De Vito T, Maraglino F, Demicheli V, Dario C, Coscioni E, Rezza G, Urbani A, Merler S, Brusaferro S; Italian COVID-19 monitoring group. Riccardo F, et al. Among authors: del manso m. Bull World Health Organ. 2022 Feb 1;100(2):161-167. doi: 10.2471/BLT.21.286317. Epub 2021 Nov 25. Bull World Health Organ. 2022. PMID: 35125541 Free PMC article.
Dengue virus infections among European travellers, 2015 to 2019.
Gossner CM, Fournet N, Frank C, Fernández-Martínez B, Del Manso M, Gomes Dias J, de Valk H. Gossner CM, et al. Among authors: del manso m. Euro Surveill. 2022 Jan;27(2):2001937. doi: 10.2807/1560-7917.ES.2022.27.2.2001937. Euro Surveill. 2022. PMID: 35027102 Free PMC article.
Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
Riccardo F, Frisicale EM, Guzzetta G, Ferraro F, Merler S, Maringhini G, Spuri M, Petrone D, Rota MC, Rapiti A, Angeloni U, Rossi P, Tallon M, Giannitelli S, Pezzotti P, Del Manso M, Bella A, Maraglino FP. Riccardo F, et al. Among authors: del manso m. Epidemiol Infect. 2022 Apr 22;150:e166. doi: 10.1017/S0950268822000723. Epidemiol Infect. 2022. PMID: 35450542 Free PMC article.
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
Mateo-Urdiales A, Sacco C, Fotakis EA, Del Manso M, Bella A, Riccardo F, Bressi M, Rota MC, Petrone D, Siddu A, Fedele G, Stefanelli P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Mateo-Urdiales A, et al. Among authors: del manso m. Lancet Infect Dis. 2023 Dec;23(12):1349-1359. doi: 10.1016/S1473-3099(23)00374-2. Epub 2023 Jul 18. Lancet Infect Dis. 2023. PMID: 37478877
Underreporting of congenital rubella in Italy, 2010-2014.
Giambi C, Bella A, Filia A, Del Manso M, Nacca G, Declich S, Rota MC; Regional contact points for rubella. Giambi C, et al. Among authors: del manso m. Eur J Pediatr. 2017 Jul;176(7):955-962. doi: 10.1007/s00431-017-2935-7. Epub 2017 May 28. Eur J Pediatr. 2017. PMID: 28551878
67 results